Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/13657
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Sophonnithiprasert T. | - |
dc.contributor.author | Mahabusarakam W. | - |
dc.contributor.author | Nakamura Y. | - |
dc.contributor.author | Watanapokasin R. | - |
dc.date.accessioned | 2021-04-05T03:25:27Z | - |
dc.date.available | 2021-04-05T03:25:27Z | - |
dc.date.issued | 2015 | - |
dc.identifier.issn | 1252208 | - |
dc.identifier.other | 2-s2.0-84957664239 | - |
dc.identifier.uri | https://ir.swu.ac.th/jspui/handle/123456789/13657 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84957664239&partnerID=40&md5=c833069ff73925d41dac55ee8d29c50d | - |
dc.description.abstract | Objective: To investigate the effect of goniothalamin on antiproliferation and apoptosis induction in three types of colorectal cancer cells. Background: Colorectal cancer is the third of the twentieth most commonly diagnosed cancer. Different types of colorectal cancer cells differ in genotype and characteristics leading to different responses to anticancer drugs. Therefore, finding new anticancer compound for the colorectal cancer cells is necessary. Material and Method: Antiproliferative response of goniothalamin on three colorectal cancer cell lines including Colo 205, SW480, and LoVo were determined by MTT assay. The antiproliferative response at different time and dose was also observed. Apoptosis induction by goniothalamin was observed in all three cell-lines via morphological changes and nuclear condensation by Hoechst33342 staining. Results: Goniothalamin showed different antiproliferative response on Colo 205, SW480, and LoVo cells at the IC50 value is 9.86+0.38 μM, 22.00+4.40 μM, and 65.25+1.85 μM, respectively. In addition, the antiproliferative response of goniothalamin was a time- and dose- dependent manner. Apoptosis morphological changes and nuclear condensation were clearly observed in Colo 205, SW480 and LoVo cells treated with 10 μM, 25 μM, and 50 μM goniothalamin, respectively. Conclusion: Goniothalamin showed antiproliferation and apoptosis induction in colorectal cancer cells with different sensitivity depending on cell type. Investigation of mechanisms underlying apoptosis and its potential use for colorectal cancer treatment should be further studied. © 2015, Medical Association of Thailand. All rights reserved. | - |
dc.subject | antineoplastic agent | - |
dc.subject | goniothalamin | - |
dc.subject | unclassified drug | - |
dc.subject | antineoplastic agent | - |
dc.subject | goniothalamin | - |
dc.subject | pyrone derivative | - |
dc.subject | antineoplastic activity | - |
dc.subject | antiproliferative activity | - |
dc.subject | apoptosis | - |
dc.subject | Article | - |
dc.subject | cell proliferation assay | - |
dc.subject | cell structure | - |
dc.subject | cell viability assay | - |
dc.subject | chromatin condensation | - |
dc.subject | colorectal cancer | - |
dc.subject | colorectal cancer cell line | - |
dc.subject | controlled study | - |
dc.subject | drug effect | - |
dc.subject | human | - |
dc.subject | human cell | - |
dc.subject | IC50 | - |
dc.subject | MTT assay | - |
dc.subject | apoptosis | - |
dc.subject | cell proliferation | - |
dc.subject | Colorectal Neoplasms | - |
dc.subject | drug effects | - |
dc.subject | tumor cell line | - |
dc.subject | Antineoplastic Agents | - |
dc.subject | Apoptosis | - |
dc.subject | Cell Line, Tumor | - |
dc.subject | Cell Proliferation | - |
dc.subject | Colorectal Neoplasms | - |
dc.subject | Humans | - |
dc.subject | Pyrones | - |
dc.title | Antiproliferation and apoptosis induction in colorectal cancer cells by goniothalamin | - |
dc.type | Article | - |
dc.rights.holder | Scopus | - |
dc.identifier.bibliograpycitation | Journal of the Medical Association of Thailand. Vol 98, (2015), p.S146-S151 | - |
Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.